Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

QuantRx Biomed Begins Blood Imaging Trials

May 2008
QuantRx Biomedical Corp. of Doylestown, Pa., has announced that Phase 1 trials have begun for the BFPET blood flow imaging agent for PET. An affiliated company, FluoroPharma Inc. of Boston will evaluate the safety, distribution and dosimetry of the agent for myocardial perfusion imaging in healthy subjects.

Biophotonicsblood flowenergymyocardial perfusion imagingNews & FeaturesQuantRx Biomedical Corp.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!